{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:15:18Z","timestamp":1767942918032,"version":"3.49.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The prevalence of both obesity and type 1 diabetes mellitus (T1DM) has increased globally over the last decades. Overweight and obesity affect individuals with T1DM and influence not only the autoimmune pathogenesis but also the long-term complications of T1DM. This study aimed to investigate the effect of excess body weight on the clinical presentation of T1DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, single-center cohort study at the largest pediatric endocrinology center in Hungary. Data were collected from children diagnosed with T1DM between 2014 and 2023. A total of 994 patients\u2019 presentation parameters and anthropometric data were analyzed. Based on BMI Z-scores, patients were categorized into three groups (normal-weight, overweight, and obese). Metabolic parameters at diagnosis were compared between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The combined ten-year prevalence of overweight and obesity was found to be 15.9%. Significant between-group differences were observed in pH (p=0.005), bicarbonate (HCO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>-<\/jats:sup>\n                      ; p=0.018), partial carbon-dioxide (pCO\n                      <jats:sub>2<\/jats:sub>\n                      ) pressure (p=0.018), and C-peptide levels (p&amp;lt; 0.001). Lower pH, pCO\n                      <jats:sub>2<\/jats:sub>\n                      and HCO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>-<\/jats:sup>\n                      levels were found among those who were overweight, and higher C-peptide levels in children with obesity. Diabetic ketoacidosis (DKA) and severe DKA were seen at a significantly higher rate among children with overweight and obesity (p=0.013; p&amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Children with overweight presented with more severe metabolic derangement at T1DM onset. Obese and overweight children have a higher risk of having DKA at presentation despite elevated C-peptide levels, which suggest a greater residual \u03b2-cell function. These findings support the hypothesis that other factors, such as chronic inflammation, may contribute to T1DM manifestation. Our findings highlight the impact of overweight and obesity on the clinical presentation of T1DM. In case of weight loss in obese and overweight children, more attention should be paid to the classical symptoms of T1DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1740046","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:14:50Z","timestamp":1767935690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Overweight worsens the metabolic presentation of type 1 diabetes mellitus in children"],"prefix":"10.3389","volume":"16","author":[{"given":"Eszter","family":"Muzslay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Herczeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roz\u00e1lia Ildik\u00f3","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilmos Zolt\u00e1n","family":"Forstreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorina","family":"So\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"T\u00f3th-Heyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Luczay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Health Promotion Perspectives"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1159\/000543035","article-title":"ISPAD clinical practice consensus guidelines 2024: screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"97","author":"Haller","year":"2024","journal-title":"Horm Res Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes\u2014early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13454","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents","volume":"23","author":"Libman","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S223618","article-title":"Obesity in patients with type 1 diabetes: links, risks and management challenges","volume":"14","author":"Vilarrasa","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s41467-022-29932-y","article-title":"Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach","volume":"13","author":"Richardson","year":"2022","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/3945064","article-title":"Dietary intake and body mass index influence the risk of islet autoimmunity in genetically at-risk children: A mediation analysis using the TEDDY cohort","volume":"2023","author":"Andr\u00e9n Aronsson","year":"2023","journal-title":"Pediatr Diabetes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-06079-z","article-title":"Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes","author":"Hummel","year":"2024","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41366-023-01429-8","article-title":"The emergence of obesity in type 1 diabetes","volume":"48","author":"Kueh","year":"2024","journal-title":"Int J Obes (Lond)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.03160.x","article-title":"Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis","volume":"28","author":"Verbeeten","year":"2011","journal-title":"Diabetes Med"},{"key":"B11","volume-title":"Report on the fifth round of data collection, 2018\u20132020: WHO European Childhood Obesity Surveillance Initiative (COSI)","year":"2022"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12730","article-title":"Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry","volume":"19","author":"Maffeis","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13406","article-title":"ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state","volume":"23","author":"Glaser","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B14","volume-title":"Az orsz\u00e1gos longitudin\u00e1lis gyermekn\u00f6veked\u00e9s vizsg\u00e1lat eredm\u00e9nyei sz\u00fclet\u00e9st\u0151l 18 \u00e9ves korig","author":"Joubert","year":"2006"},{"key":"B15","volume-title":"The Hungarian Longitudinal Growth Study: From birth to the age of 18 years","author":"Joubert","year":"2016"},{"key":"B16","article-title":"SWEET-Benchmarking, Center: 10214-HU, Semmelweis University, Data analysis based on SWEETBASE datapool focused on: 01\/01\/2023 - 31\/12\/2023, Starting year of the analysis: 2010","author":"Hungele RR","year":"2023"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"110691","DOI":"10.1016\/j.diabres.2023.110691","article-title":"Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions","volume":"200","author":"Suren Garg","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193001","article-title":"Macrophages, chronic inflammation, and insulin resistance","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129191","article-title":"Contribution of adipogenesis to healthy adipose tissue expansion in obesity","volume":"129","author":"Vishvanath","year":"2019","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease","volume":"35","author":"Lee","year":"2021","journal-title":"Genes Dev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13724","article-title":"Inflammation-mediated metabolic regulation in adipose tissue","volume":"25","author":"Xu","year":"2024","journal-title":"Obes Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.887702","article-title":"Autoimmunity as a sequela to obesity and systemic inflammation","volume":"13","author":"Kwiat","year":"2022","journal-title":"Front Physiol"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.890833","article-title":"Multi-faceted influence of obesity on type 1 diabetes in children \u2013 from disease pathogenesis to complications","volume":"13","author":"Ci\u0119\u017cki","year":"2022","journal-title":"Front Endocrinol"},{"key":"B25","article-title":"Children and adolescents: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B26","first-page":"1","article-title":"Use of GLP-1 receptor agonists for the management of type 1 diabetes: A pediatric perspective","author":"Shenker","year":"2024","journal-title":"Hormone Res Pediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13234","article-title":"Use of glucagon-like peptide-1 receptor agonists for pediatric patients with obesity and diabetes: The providers\u2019 perspectives","volume":"22","author":"Gourgari","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/children12010110","article-title":"Severe diabetic ketoacidosis in children with type 1 diabetes: ongoing challenges in care","volume":"12","author":"Foti Randazzese","year":"2025","journal-title":"Children (Basel)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1740046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:14:51Z","timestamp":1767935691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1740046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":28,"alternative-id":["10.3389\/fendo.2025.1740046"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1740046","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1740046"}}